Clinical Trial Update: Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating Xianglei Tangzu Gao for diabetic foot ulcers is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Xianglei Tangzu Gao

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING